P2X7 Receptor Promotes Mouse Mammary Cancer Cell Invasiveness and Tumour Progression, and Is a Target for Anticancer

Lucie Brisson1, Stéphanie Chadet2, Osbaldo Lopez-Charcas2

  • 1Inserm UMR1069-Nutrition, Growth and Cancer, University of Tours, 37032 Tours, France.

Cancers
|August 23, 2020
PubMed

Insights

The P2X7 receptor drives aggressive mammary cancer progression by promoting cell invasiveness and metastasis. Blocking this receptor with antagonists effectively reduced tumor growth in mouse models, highlighting its therapeutic potential.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • The P2X7 receptor's role in cancer progression is controversial, with potential pro- or anti-cancer effects.
  • Its specific function in mammary cancer remains undefined.

Purpose of the Study:

  • To investigate the role of the P2X7 receptor in mammary cancer progression.
  • To determine if P2X7 receptor is a viable therapeutic target for mammary cancer.

Main Methods:

  • Functional assays in aggressive mammary cancer cells.
  • In vitro invasion assays using 2D and 3D extracellular matrices.
  • In vivo studies using an immunocompetent mouse mammary cancer model.
  • Treatment with specific P2X7 receptor antagonists.

Main Results:

  • P2X7 receptor is functional in aggressive mammary cancer cells, inducing morphological changes and promoting invasiveness.
  • P2X7 receptor sustains Cdc42 activity and mesenchymal phenotype acquisition.
  • In vivo, P2X7 receptor expression in cancer cells promoted tumor growth and metastasis, which were reduced by antagonists.

Conclusions:

  • The P2X7 receptor actively drives mammary tumor progression and metastasis.
  • Targeting the P2X7 receptor with antagonists shows promise for mammary cancer treatment.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K